09:56 AM EST - Aurora Cannabis Inc. : Has announced today the availability of medical cannabis concentrates to patients in the United Kingdom (U.K.). This launch marks the company's meaningful step in offering its proprietary cultivar-specific inhalable cannabis extracts in the U.K. market. These products are available to patients in Canada and Australia and this launch reinforces Aurora's commitment to expanding patient access to an even greater variety of high-quality, premium medical cannabis globally. Aurora Cannabis Inc.
shares T.ACB are trading up $0.02 at $5.90.
